Skip to main content
Journal cover image

PAX3-FOXO1 fusion gene in rhabdomyosarcoma.

Publication ,  Journal Article
Linardic, CM
Published in: Cancer Lett
October 18, 2008

Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma of childhood and adolescence. The predominant histologic variants of this disease are termed embryonal (eRMS) and alveolar (aRMS), based on their appearance under light microscopy. Of the two, aRMS is associated with an more aggressive disease pattern and a higher mortality, mandating a better understanding of this cancer at the molecular level. The PAX3-FOXO1 fusion gene, resulting from the stable reciprocal translocation of chromosomes 2 and 13, is a signature genetic change found only in aRMS, and thought to be responsible at least in part for its malignant phenotype. This review will discuss the clinical significance of the PAX3-FOXO1 fusion gene, the pertinent historical and current models used to study its oncogenic contributions, the transcriptional targets that are thought to mediate these contributions, and the cellular mechanisms impacted by PAX3-FOXO1 that ultimately lead to aRMS.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Cancer Lett

DOI

EISSN

1872-7980

Publication Date

October 18, 2008

Volume

270

Issue

1

Start / End Page

10 / 18

Location

Ireland

Related Subject Headings

  • Vascular Endothelial Growth Factor Receptor-1
  • Transcription, Genetic
  • Rhabdomyosarcoma
  • Paired Box Transcription Factors
  • Oncology & Carcinogenesis
  • Oncogene Proteins, Fusion
  • Humans
  • Forkhead Transcription Factors
  • Forkhead Box Protein O1
  • Chemokine CXCL12
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Linardic, C. M. (2008). PAX3-FOXO1 fusion gene in rhabdomyosarcoma. Cancer Lett, 270(1), 10–18. https://doi.org/10.1016/j.canlet.2008.03.035
Linardic, Corinne M. “PAX3-FOXO1 fusion gene in rhabdomyosarcoma.Cancer Lett 270, no. 1 (October 18, 2008): 10–18. https://doi.org/10.1016/j.canlet.2008.03.035.
Linardic CM. PAX3-FOXO1 fusion gene in rhabdomyosarcoma. Cancer Lett. 2008 Oct 18;270(1):10–8.
Linardic, Corinne M. “PAX3-FOXO1 fusion gene in rhabdomyosarcoma.Cancer Lett, vol. 270, no. 1, Oct. 2008, pp. 10–18. Pubmed, doi:10.1016/j.canlet.2008.03.035.
Linardic CM. PAX3-FOXO1 fusion gene in rhabdomyosarcoma. Cancer Lett. 2008 Oct 18;270(1):10–18.
Journal cover image

Published In

Cancer Lett

DOI

EISSN

1872-7980

Publication Date

October 18, 2008

Volume

270

Issue

1

Start / End Page

10 / 18

Location

Ireland

Related Subject Headings

  • Vascular Endothelial Growth Factor Receptor-1
  • Transcription, Genetic
  • Rhabdomyosarcoma
  • Paired Box Transcription Factors
  • Oncology & Carcinogenesis
  • Oncogene Proteins, Fusion
  • Humans
  • Forkhead Transcription Factors
  • Forkhead Box Protein O1
  • Chemokine CXCL12